
Ready Meals Market Share, Size, Trends, Industry Analysis Report, By Product (Chilled, Frozen, Shelf-stable, Canned); By Meal Type (Vegan, Vegetarian, Non-vegetarian); By Distribution Channel; By Region; Segment Forecast, 2022 - 2030
Description
The global ready meals market size is expected to reach USD 289.29 billion by 2034 according to a new study by Polaris Market Research. The report “Ready Meals Market Share, Size, Trends, Industry Analysis Report, By Product (Chilled, Frozen, Shelf-stable, Canned); By Meal Type (Vegan, Vegetarian, Non-vegetarian); By Distribution Channel; By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The industry is primarily driven by the product's extended storage lifetime as a result of adequate packing and widespread accessibility. Furthermore, because of increasing hectic work schedules and shifting lifestyles, customers are gravitating towards packaged foods that can be consumed quickly and effortlessly, which has increased the demand for packed ready-to-eat food items and is expected to increase throughout the forecast period.
Convenience meals are gaining prominence, and they are made up of fully or half-cooked dishes that require minimal time to make, no cooking expertise, and negligible exertion. Moreover, the digitization surge and vigorous ads regarding cooked foods on different communication platforms help raise consumer knowledge, which in turn is expected to propel the ready meals industry throughout the forecast period.
The non- vegetarian segment is expected to hold a significant share in the industry over the forecast period due to increasing demand for fresh hygiene non-vegetarian food items. However, the vegan segment is anticipated to grow at a considerable pace due to rising trends in healthy food coupled with increasing concerns regarding animal welfare.
The North American region is expected to dominate the industry throughout the forecast period due to the increasing adoption of convenience food coupled with the growing demand for high-quality packed food due to busy lifestyles. Furthermore, increasing trends in veganism and gluten-free products are expected to contribute to the regional development.
Market players operating in the global ready meals such as Chao Xiang Yuan Food Co. Ltd., Associated British Foods Plc, Dr. Oetker, Pepsico., Conagra Foods Inc., General Mills, Green Mill Food, Graham Packaging Company, Greencore Group Plc, Kerry Group, Kraft Heinz Company, Grupo Bimbo, Kellogg Company, McCain Foods Limited, Maple Leaf Foods, Nestle, Premier Foods Plc, Tyson Foods, Inc, Tetra Pak International S.A., Unilever, and WestRock Company.
Polaris market research has segmented the ready meals market report based product, meal type, distribution channel, and region:
Ready Meals, Product Outlook (Revenue - USD Billion, 2020 - 2034)
Chilled
Frozen
Shelf-stable
Canned
Ready Meals, Meal Type Outlook (Revenue - USD Billion, 2020 - 2034)
Vegan
Vegetarian
Non-vegetarian
Ready Meals, Distribution Channel Outlook (Revenue - USD Billion, 2020 - 2034)
Convenience Stores
Supermarkets & Hypermarkets
Online
Others
Ready Meals, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S
Canada
Europe
France
Germany
UK
Italy
Netherlands
Russia
Spain
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
The industry is primarily driven by the product's extended storage lifetime as a result of adequate packing and widespread accessibility. Furthermore, because of increasing hectic work schedules and shifting lifestyles, customers are gravitating towards packaged foods that can be consumed quickly and effortlessly, which has increased the demand for packed ready-to-eat food items and is expected to increase throughout the forecast period.
Convenience meals are gaining prominence, and they are made up of fully or half-cooked dishes that require minimal time to make, no cooking expertise, and negligible exertion. Moreover, the digitization surge and vigorous ads regarding cooked foods on different communication platforms help raise consumer knowledge, which in turn is expected to propel the ready meals industry throughout the forecast period.
The non- vegetarian segment is expected to hold a significant share in the industry over the forecast period due to increasing demand for fresh hygiene non-vegetarian food items. However, the vegan segment is anticipated to grow at a considerable pace due to rising trends in healthy food coupled with increasing concerns regarding animal welfare.
The North American region is expected to dominate the industry throughout the forecast period due to the increasing adoption of convenience food coupled with the growing demand for high-quality packed food due to busy lifestyles. Furthermore, increasing trends in veganism and gluten-free products are expected to contribute to the regional development.
Market players operating in the global ready meals such as Chao Xiang Yuan Food Co. Ltd., Associated British Foods Plc, Dr. Oetker, Pepsico., Conagra Foods Inc., General Mills, Green Mill Food, Graham Packaging Company, Greencore Group Plc, Kerry Group, Kraft Heinz Company, Grupo Bimbo, Kellogg Company, McCain Foods Limited, Maple Leaf Foods, Nestle, Premier Foods Plc, Tyson Foods, Inc, Tetra Pak International S.A., Unilever, and WestRock Company.
Polaris market research has segmented the ready meals market report based product, meal type, distribution channel, and region:
Ready Meals, Product Outlook (Revenue - USD Billion, 2020 - 2034)
Chilled
Frozen
Shelf-stable
Canned
Ready Meals, Meal Type Outlook (Revenue - USD Billion, 2020 - 2034)
Vegan
Vegetarian
Non-vegetarian
Ready Meals, Distribution Channel Outlook (Revenue - USD Billion, 2020 - 2034)
Convenience Stores
Supermarkets & Hypermarkets
Online
Others
Ready Meals, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S
Canada
Europe
France
Germany
UK
Italy
Netherlands
Russia
Spain
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
115 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Insights
- 4.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market – Market Snapshot
- 4.2. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Aging Population and Demographic Shift
- 4.2.1.2. Rising Healthcare Spending
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory and market access barriers
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Trends
- 4.6. Value Chain Analysis
- 5. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Type, 2020-2034 (USD Million)
- 5.3. Therapy
- 5.3.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Therapy, by Region, 2020-2034 (USD Million)
- 5.3.2. Chemotherapy
- 5.3.2.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Chemotherapy, by Region, 2020-2034 (USD Million)
- 5.3.3. Immunotherapy
- 5.3.3.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Immunotherapy, by Region, 2020-2034 (USD Million)
- 5.3.4. Stem Cell Transplantation
- 5.3.4.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Stem Cell Transplantation, by Region, 2020-2034 (USD Million)
- 5.4. Diagnostic
- 5.4.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Diagnostic, by Region, 2020-2034 (USD Million)
- 5.4.2. Flow Cytometry
- 5.4.2.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Flow Cytometry, by Region, 2020-2034 (USD Million)
- 5.4.3. Molecular Testing
- 5.4.3.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Molecular Testing, by Region, 2020-2034 (USD Million)
- 5.4.4. Histopathology
- 5.4.4.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Histopathology, by Region, 2020-2034 (USD Million)
- 5.4.5. Imaging Techniques
- 5.4.5.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Imaging Techniques, by Region, 2020-2034 (USD Million)
- 6. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by End User
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by End User, 2020-2034 (USD Million)
- 6.3. Hospitals
- 6.3.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Hospitals, by Region, 2020-2034 (USD Million)
- 6.4. Specialty Clinics
- 6.4.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
- 6.5. Diagnostic Laboratories
- 6.5.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
- 6.6. Others
- 6.6.1. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market, by Others, by Region, 2020-2034 (USD Million)
- 7. Competitive Landscape
- 7.1. Expansion and Acquisition Analysis
- 7.1.1. Expansion
- 7.1.2. Acquisitions
- 7.2. Partnerships/Collaborations/Agreements/Exhibitions
- 8. Company Profiles
- 8.1. AbbVie Inc.
- 8.1.1. Company Overview
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.1.4. Recent Development
- 8.2. Jazz Pharmaceuticals, Inc.
- 8.2.1. Company Overview
- 8.2.2. Financial Performance
- 8.2.3. Product Benchmarking
- 8.2.4. Recent Development
- 8.3. Menarini Group
- 8.3.1. Company Overview
- 8.3.2. Financial Performance
- 8.3.3. Product Benchmarking
- 8.3.4. Recent Development
- 8.4. Sanofi
- 8.4.1. Company Overview
- 8.4.2. Financial Performance
- 8.4.3. Product Benchmarking
- 8.4.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.